In a filing, PTC Therapeutics Inc revealed its Officer Boulding Mark Elliott acquired Company’s shares for reported $0.21 million on Nov 17 ’25. In the deal valued at $75.01 per share,2,812 shares were bought.
Then, Reeve Emma sold 7,333 shares, generating $546,308 in total proceeds. Upon selling the shares at $74.50, the Director now owns 6,666 shares.
Before that, Reeve Emma bought 7,333 shares. PTC Therapeutics Inc shares valued at $546,308 were divested by the Director at a price of $74.50 per share.
Wells Fargo initiated its PTC Therapeutics Inc [PTCT] rating to an Overweight in a research note published on October 20, 2025; the price target was $73. A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in mid June with a ‘”a Buy”‘ rating. BofA Securities also remained covering PTCT and has increased its forecast on May 09, 2025 with a “Buy” recommendation from previously “Neutral” rating. Citigroup revised its rating on May 07, 2025. It rated PTCT as “a Neutral” which previously was an “a Sell”.
Price Performance Review of PTCT
On Monday, PTC Therapeutics Inc [NASDAQ:PTCT] saw its stock jump 0.40% to $75.6. Over the last five days, the stock has gained 4.30%. PTC Therapeutics Inc shares have risen nearly 71.70% since the year began. Nevertheless, the stocks have risen 67.48% over the past one year. While a 52-week high of $76.80 was reached on 11/17/25, a 52-week low of $35.95 was recorded on 05/06/25.
Levels Of Support And Resistance For PTCT Stock
The 24-hour chart illustrates a support level at 74.38, which if violated will result in even more drops to 73.15. On the upside, there is a resistance level at 77.13. A further resistance level may holdings at 78.65.
How much short interest is there in PTC Therapeutics Inc?
A steep rise in short interest was recorded in PTC Therapeutics Inc stocks on 2025-10-31, growing by 1.2 million shares to a total of 8.34 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 7.14 million shares. There was a rise of 14.4%, which implies that there is a positive sentiment for the stock.
